Dr. Jamuna K. Krishnan
Pulmonology (Pulmonary Disease Physician)
505 E 70th St, Weill Cornell Internal Medicine Associates
New York, NY 10021
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 91
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Michigan Medical School
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
NY license 283436 -
Critical Care Medicine (Internal Medicine) Physician
NY license 283436-1 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
Medical groups
- Weill Medical College of Cornell (2,051 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 91
- Services billed
- 174
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 16 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in New York, NY | 52 |
| Bevespi Aerosphere (glycopyrrolate/formoterol fum) Other prescribers in New York, NY | 27 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in New York, NY | 22 |
| Fluticasone Propionate Other prescribers in New York, NY | 21 |
| Montelukast Sodium Other prescribers in New York, NY | 20 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in New York, NY | 17 |
| Levocetirizine Dihydrochloride Other prescribers in New York, NY | 16 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in New York, NY | 12 |
| Combivent Respimat (ipratropium/albuterol sulfate) Other prescribers in New York, NY | 12 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in New York, NY | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $41,445 in research payments for these studies, mostly to the institutions running them.
- A Randomized DoubleBlind Parallel Group Multi Center Phase III Study to Assess the Efficacy of Budesonide Glycopyrronium and Formoterol Fumarate MeterednDose Inhaler Relative to Glycopyrronium and Formoterol Fumarate …
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.